Loading...
The Financial Express

India to produce 100 million doses of Russia's Covid vaccine

| Updated: November 28, 2020 11:56:07


Evaly and Fianancial Express Evaly and Fianancial Express
Bottles with Russia's 'Sputnik-V' vaccine for the coronavirus disease (Covid-19) are seen before inoculation at a clinic in Tver, Russia on October 12, 2020 — Reuters/Files Bottles with Russia's 'Sputnik-V' vaccine for the coronavirus disease (Covid-19) are seen before inoculation at a clinic in Tver, Russia on October 12, 2020 — Reuters/Files

Russia’s sovereign wealth fund and Indian pharmaceutical company Hetero have agreed to produce over 100 million doses per year in India of the Sputnik V vaccine against Covid-19, according to a statement on the Sputnik V Twitter account on Friday.

Hetero and the Russian Direct Investment Fund (RDIF), which has been backing the vaccine and marketing it globally, plan to start production of Sputnik V in India at the beginning of 2021, the statement said.

Phase II-III trials are ongoing in India, the statement said. Drugmaker Dr Reddy’s Laboratories Ltd has said it expects late-stage trials to be completed by as early as March 2021.

Share if you like